Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar Biotech2010 (87.42) Submitted: 1/26/2010 8:50:26 PM : Outperform Start Price: $7.18 ALTH Score: -96.65

@6.58

Featured Broker Partners


Advertisement